Warnock, Peers Propose Bipartisan $35 Monthly Cap on Insulin

U.S. Senators Introduce INSULIN Act of 2026

In a bid to bring much-needed relief to diabetics, U.S. Senators Reverend Raphael Warnock (D-GA), Jeanne Shaheen (D-NH), Susan Collins (R-ME), and John Kennedy (R-LA) have launched the INSULIN Act of 2026. The legislation aims to cap the out-of-pocket insulin expenses at $35 per month for private insurance holders nationwide and works to lower the cost for uninsured diabetics.

A Step Forward in Diabetes Treatment

The latest iteration of the INSULIN Act enhances the previous legislation that capped insulin costs for senior citizens. The new provision, initiated by Senator Warnock, paves the way for a 10-state pilot grant program that allows community health centers to provide affordable insulin to uninsured patients. Additionally, the bill establishes an insulin resource center and hotline to guide uninsured diabetics in getting the insulin they require.

Senator Warnock, who previously enacted a law in 2022 capping insulin costs for seniors, expressed his pride in growing the bipartisan support for affordable insulin. In his words, “Our legislation also provides a pathway of funding to community health centers so they can continue reaching people who would benefit from insulin priced at $35 or less. No one should be forced to put their health or life in danger because they can’t afford insulin or don’t know where to get it.”

A Steady Push for Affordable Insulin

Since joining the Senate in 2022, Senator Warnock has been an active advocate for reducing insulin costs for Georgians. He has regularly introduced legislation to lower insulin costs and fight for fairer prescription drug prices. His efforts include the Affordable Insulin Now Act of 2023, which sought to cap everyone’s insulin costs at $35.

In the same year, along with Senator Kennedy, Warnock released a report analyzing county-level data across the nation to spot counties with high rates of uninsured people and diabetes prevalence, termed as “Insulin Deserts”.

Rising Costs, Rising Concerns

Diabetes treatment costs have been on a steady rise for Americans, with insulin prices nearly doubling from 2012 to 2021, according to the Health Care Costs Institute. The American Diabetes Association has revealed that the total lost work, wages, and medical costs for diagnosed diabetes patients tally up to a whopping $412.9 billion each year, and claimed that diabetics account for $1 of every $4 spent on U.S. healthcare.

To read the full text of the INSULIN Act of 2026, click HERE.